At Luminance Health we foster meaningful growth in Life Science. With our cross-functional consulting services, we support pharma, biotech and medtech organizations to achieve sustainable success and continuously uphold industry standards while navigating dynamic and international regulatory landscapes across the lifecycle of medicinal products, devices, IVDs and combination products. We provide personalized, expert-led, cross-functional support in development, regulatory affairs, quality assurance, pharmacovigilance, medical and regulatory communications, market access, public affairs, healthcare compliance, project management, establishing and scaling-up companies. With our offices in Switzerland and Austria as well as our strategic partners across the globe, we support access to markets for our clients globally.

Swissmedic License: GxP Quality Management System

Our Swissmedic licence is the cornerstone of our commitment to the highest standards of Good Practice (GxP). Supported by a fully implemented Quality Management System that meets Swissmedic’s requirements, we ensure every stage is rigorously documented, controlled and subject to continuous review.

SME Status: Enabling EMA Access for Non-EU Innovators

As a certified Small and Medium-sized Enterprise (SME) under European Medicines Agency criteria, we specialise in navigating non-EU clients through the EMA submission process. By combining bespoke guidance with deep EMA expertise, we empower innovators outside the EU to deliver vital therapies to European patients more swiftly and cost-effectively.

News

Luminance Health is Great Place To Work® Certified ™

Luminance Health is proud to be Certified™ by Great Place To Work®, a milestone that reflects the strong culture and team spirit built across the organization. This prestigious recognition is based entirely on direct employee feedback about their experience working at Luminance Health.
Basel, Switzerland | 26.01.2026

Strengthening Partnerships and Advancing Growth in 2026

As we enter 2026, Luminance extends its sincere appreciation to all clients and partners for their continued trust. Your collaboration enables us to support you in navigating complex regulatory, quality, and market environments with precision and purpose, delivering clarity, compliance, and strategic advantage across an increasingly competitive life science landscape. In the year ahead, we will continue to operate with the highest standards of rigor, transparency, and operational excellence. Our cross‑functional expertise, spanning regulatory affairs, quality, pharmacovigilance, medical communication, market access, and public affairs, remains focused on supporting your ambitions with solutions that are actionable, scalable, and aligned with evolving global expectations. Together, we will continue building resilient pathways to innovation, strengthening stakeholder confidence, and enabling sustainable, meaningful growth. From the entire Luminance team, we wish you a successful and impactful 2026. We look forward to shaping the future of life sciences together.
Basel, Switzerland | 02.01.2026

Luminance Health CEO Shayesteh Fürst-Ladani elected President of POWHER – Female Entrepreneurs Basel

Luminance Health is proud to announce that our CEO, Shayesteh Fürst-Ladani, has been elected President of POWHER – Female Entrepreneurs Basel, a dynamic community of volunteers dedicated to building networks, celebrating female entrepreneurship, and driving systemic change in the Basel region. POWHER, founded in 2022 with the support of the University of Basel’s Innovation Office, FEMtrepreneurs, Impact Hub Basel, Basel Area Business & Innovation, and Startup Academy Schweiz, is committed to creating public awareness and visibility for women entrepreneurs and advocates. The association’s flagship initiative, the POWHER Awards, shines a spotlight on innovative women-led startups and champions of diversity, equity, and inclusion in the entrepreneurial ecosystem. Despite progress, women remain significantly underrepresented in entrepreneurship, with only 15% of startups having a female co-/founder. Female CEOs also receive substantially less funding than their male peers under similar conditions. Through her new role, Shayesteh Fürst-Ladani will help amplify the visibility of women in business and empower the next generation of female leaders to shape the future of innovation. At Luminance Health, we believe in the power of representation and inclusive leadership. Shayesteh Fürst-Ladani’s dedication to advancing gender equity and her proven track record as a leader, entrepreneur, and advocate make her the perfect fit to lead this important mission. We look forward to supporting POWHER’s work in creating a more equitable entrepreneurial ecosystem in Basel and beyond.
Basel, Switzerland | 25.09.2025
Luminance Health AG Zwingerstrasse 10 4053 Basel Switzerland
©
2026
Luminance Health AG
Follow us: